Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia.
Badar T, Luthra R, Kantarjian H, Jabbour E, Borthakur G, Garcia-Manero G, Huang X, Singh R, Alvarez B, Austermiller B, Morrison TB, Patel KP, Cortes J. Badar T, et al. Appl Immunohistochem Mol Morphol. 2019 Jan;27(1):33-39. doi: 10.1097/PAI.0000000000000526. Appl Immunohistochem Mol Morphol. 2019. PMID: 28682832
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies.
Badar T, Cortes JE, Ravandi F, O'Brien S, Verstovsek S, Garcia-Manero G, Kantarjian H, Borthakur G. Badar T, et al. Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):433-438.e2. doi: 10.1016/j.clml.2015.02.018. Epub 2015 Feb 19. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25795639 Free PMC article. Clinical Trial.
Phase II, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytarabine.
Badar T, Cortes J, Borthakur G, O'Brien S, Wierda W, Garcia-Manero G, Ferrajoli A, Kadia T, Poku R, Kantarjian H, Mattiuzzi G. Badar T, et al. Biomed Res Int. 2015;2015:497597. doi: 10.1155/2015/497597. Epub 2015 Jan 15. Biomed Res Int. 2015. PMID: 25654108 Free PMC article. Clinical Trial.
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.
Badar T, Handisides DR, Benito JM, Richie MA, Borthakur G, Jabbour E, Harutyunyan K, Konoplev S, Faderl S, Kroll S, Andreeff M, Pearce T, Kantarjian HM, Cortes JE, Thomas DA, Konopleva M. Badar T, et al. Am J Hematol. 2016 Aug;91(8):800-5. doi: 10.1002/ajh.24415. Epub 2016 Jun 25. Am J Hematol. 2016. PMID: 27169385 Free PMC article. Clinical Trial.
Ibrutinib: a paradigm shift in management of CLL.
Badar T, Burger JA, Wierda WG, O'Brien S. Badar T, et al. Expert Rev Hematol. 2014 Dec;7(6):705-17. doi: 10.1586/17474086.2014.977862. Expert Rev Hematol. 2014. PMID: 25387837 Free PMC article. Review.
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Badar T, Hari P, Dávila O, Fraser R, Wirk B, Dhakal B, Freytes CO, Rodriguez Valdes C, Lee C, Vesole DH, Malek E, Hildebrandt GC, Landau H, Murthy HS, Lazarus HM, Berdeja JG, Meehan KR, Solh M, Diaz MA, Kharfan-Dabaja MA, Callander NS, Farhadfar N, Bashir Q, Kamble RT, Vij R, Munker R, Kyle RA, Chhabra S, Hashmi S, Ganguly S, Jagannath S, Nishihori T, Nieto Y, Kumar S, Shah N, D'Souza A. Badar T, et al. Cancer. 2021 Jan 1;127(1):82-92. doi: 10.1002/cncr.33208. Epub 2020 Sep 23. Cancer. 2021. PMID: 32966625 Free PMC article.
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
Badar T, Szabo A, Litzow M, Burkart M, Yurkiewicz I, Dinner S, Hefazi M, Shallis RM, Podoltsev N, Patel AA, Curran E, Wadleigh M, Balasubramanian S, Yang J, Arslan S, Aldoss I, Mattison R, Cenin D, Siebenaller C, Advani A, Liedtke M, Atallah E. Badar T, et al. Bone Marrow Transplant. 2021 Aug;56(8):1998-2004. doi: 10.1038/s41409-021-01279-w. Epub 2021 Apr 6. Bone Marrow Transplant. 2021. PMID: 33824440
Prospect of CAR T-cell therapy in acute myeloid leukemia.
Badar T, Manna A, Gadd ME, Kharfan-Dabaja MA, Qin H. Badar T, et al. Expert Opin Investig Drugs. 2022 Feb;31(2):211-220. doi: 10.1080/13543784.2022.2032642. Epub 2022 Jan 24. Expert Opin Investig Drugs. 2022. PMID: 35051347
109 results